Загрузка...
Shared decision making in type 2 diabetes with a support decision tool that takes into account clinical factors, the intensity of treatment and patient preferences: design of a cluster randomised (OPTIMAL) trial
BACKGROUND: No more than 10-15% of type 2 diabetes mellitus (T2DM) patients achieve all treatment goals regarding glycaemic control, lipids and blood pressure. Shared decision making (SDM) should increase that percentage; however, not all support decision tools are appropriate. Because the ADDITION-...
Сохранить в:
| Опубликовано в: : | BMC Fam Pract |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4369865/ https://ncbi.nlm.nih.gov/pubmed/25887759 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12875-015-0230-0 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|